Company: MSTR
Filing Date: 2025-11-04
Form Type: 424B5
Source: 0001193125-25-263731
Chunk: 0

Company: Strategy Inc
Filing Date: 2025-11-04
Form: 424B5
Chunk 0
---
As Filed Pursuant to Rule 424(b)(5)
Registration No. 333-284510 PROSPECTUS SUPPLEMENT (To Prospectus Supplement Dated November 4, 2025, and Prospectus Dated January 27, 2025) CLASS A COMMON STOCK ANNEX Class A Common Stock We have entered into an Omnibus Sales Agreement (the “Sales Agreement”) with TD Securities (USA) LLC, Barclays Capital Inc., The Benchmark Company, LLC, BTIG, LLC, Canaccord Genuity LLC, Cantor Fitzgerald & Co., Clear Street LLC, Compass Point Research & Trading, LLC, H.C. Wainwright & Co., LLC, Keefe, Bruyette & Woods, Inc., Maxim Group LLC, Mizuho Securities USA LLC, Morgan Stanley & Co. LLC, Santander US Capital Markets LLC, SG Americas Securities, LLC, and TCBI Securities Inc. doing business as Texas Capital Securities (collectively, the “Agents”), dated November 4, 2025, relating to the sale of shares of our class A common stock, par value $0.001 per share, and shares of several series of our preferred stock, par value $0.001 per share. In accordance with the terms of the Sales Agreement, under this prospectus supplement relating to the sale of our class A common stock (the “Common Stock Annex”), we may offer and sell shares of our class A common stock having an aggregate offering price of up to $15,854,365,265.54 from time to time through one or more of the Agents, acting as our sales agents. The shares of class A common stock offered hereunder are among the securities described in the base prospectus supplement dated November 4, 2025, that we filed with the Securities and Exchange Commission (the “SEC”) on such date (the “base prospectus supplement”) and an accompanying prospectus dated January 27, 2025. This Common Stock Annex should be read in conjunction with that base prospectus supplement and accompanying prospectus and the contents of that base prospectus supplement and accompanying prospectus are incorporated by reference into this Common Stock Annex. We had previously registered the offer, issuance and sale of up to $21,000,000,000 of our class A common stock under a prospectus supplement dated May 1, 2025. Prior to the date of this Common Stock Annex, we have sold 13,032,625 shares of class A common stock under such prior prospectus